chrisvoncsefalvay/vaers-outcomes huggingface dataset:
not taste her coffee; fever; headache; still runs warm now; This is a spontaneous report from a contactable consumer (patient). A female patient of (Age: 64; Unit: Unknown) received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection), via an unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date the patient experienced not taste her coffee, fever, headache and still runs warm now. The outcome of events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
I started menstrating the night of my first dose. Menstration came 2 weeks early. It was the worst menstration cycle I have ever had in my life.  I have been spotting daily since 9/11/21. My period did not come during it's usual week.   Weekend of October 1 to 7 of 2021 I had a Gastritis flare up that has not occurred in 7 years. I did not have anything abnormal. It was the worst flare up I have experienced. I ended up in the ER at Hospital for relief.
Had seizure-like activity approximately 24 hours after receiving Pentacel. Fell to floor, stiffened, lasted approximately 20 seconds.
19 days after receiving Td vaccine I developed moderate pain in both hips and thighs.  On the 21st day post injection the pain I developed moderate bilateral leg weakness.  By the 23rd day post injection the leg weakness became so severe I was unable to walk at all and took a severe fall.  My wife took me to my Doctor the next morning with the lifting help of my sons and I was directly admitted to the Neuro-Intensive care unit at the Hospital.  I was in the Hospital for 9 days and after being diagnosed I was then transferred to a Rehabilitation Center for 23 days. I am now receiving outpatient rehab and I am still confined to a wheelchair.
This spontaneous report was received from a other health professional regarding unknown number of patients of unknown demographics. No concurrent condition and historical medication was reported. On an unknown date, unknown number of patients were vaccinated with improperly stored PROQUAD lot # K019101, expiration date- 15-APR-2016 and lot # L002213, expiration date- 21-JUL-2016. No adverse event was reported. No product quality complaint was involved. No concomitant medication was reported. The outcome of the vent was unknown. This is one of several reports received from the same reporter. Additional information is not expected because reporter did not want to get contacted.
Within a day, my son started to experience symptoms of a cold/slight fever, which we were always told was "normal". As the days progressed, he began to get more weak, lack of appetite, and you could see his breathing declining. Still thinking this was a normal reaction, I kept going about our week. I reached out to Dr. to express our concern and was told that the reaction was "normal", he asked the normal questions, is he still peeing, alert, playing (and he was until a week after the vaccination). That's when his breathing became increasingly difficult (shoulder shrugging, struggling to talk or breathe). I was still giving him Tylenol/Motrin to treat the slight fever, which had, by the time we finally got an appointment to see Dr., both his breathing was so severe and his temperature, holding steady at 103 degrees.
This case was reported by a nurse via call center representative and described the occurrence of hives in a 16-year-old female patient who received HAVRIX pediatric (batch number 93B2D, expiry date 21st November 2017). Concomitant products included GARDASIL and Birth Control. On 1st February 2016, the patient received the 2nd dose of HAVRIX pediatric (intramuscular). On 1st February 2016, 4 hrs after receiving HAVRIX pediatric, the patient experienced hives (serious criteria other: as per reporter). The patient was treated with BENADRYL. On an unknown date, the outcome of the hives was not recovered/not resolved. The reporter considered the hives to be almost certainly related to HAVRIX pediatric. Additional details were provided as follows: The nurse reported that a patient developed hives after receiving a HAVRIX and GARDASIL vaccine. The vaccine was administered on 1st February 2016, in the morning at 8.00 and the patient's mother called after lunch the same day. The patient was instructed to take BENADRYL to prevent the spread of hives. The reporter thought that the hives might be worse at the time of reporting, since the family called again and the patient would be seen by the office. The reporter stated that this event was also reported to Merck.
Sore arm, not too bad, maybe a little worse than other vaccines; This is a spontaneous report from a non-contactable consumer (patient). This This adult female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at single dose on an unspecified date for COVID-19 immunization. Medical history and concomitant medication were not reported. It was unknown if other vaccine was in four weeks; other medications in two weeks were unknown. Known allergies was unknown. If covid prior vaccination was unknown. If covid tested post vaccination was unknown. Patient experienced sore arm, not too bad, maybe a little worse than other vaccines. No treatment received. The outcome of event was recovered.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
minor fatigue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558).  A female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administration date 08Mar2021 (Batch/Lot number: unknown) as dose 1, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FATIGUE (non-serious) with onset Mar2021, outcome "unknown", described as "minor fatigue".  Additional information: The report was received from a Pfizer-sponsored program. This report is for the reporter's wife.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021662563 Same reporter, suspect product and events; different patient
localized rash to low back, rash is dry, erythematous, small, papular, non tender, non vesicular, non crusting rash
Uncontrollable chills, sweat, low grade fever, body aches,  headache, nausea, vomiting, burning sensation in chest, hallucinatory feeling, rapid breathing, couldn't sit, couldn't stand
After leaving the clinic patient was invloved in motor vechicle accident where he was air-lifted to hospital.
15 minutes after shot, I Became dizzy and dazed feeling; extremely hot; skin flushing and blotches....all lasting about 1-1.5 hours. Then a feeling of raciness, a feeling of jittery the lasted all day.  By 8pm I had vigorous shaking chills all night; severe muscle/joint aches and a fever of 101.6 at midnight.  The next day all this stopped but I had zero energy and had to stay on recliner or in bed napping off and on all day.  By Thursday I woke up completely feeling normal.
Can I take a pain reliever for the side effects; This non-serious case was reported by a consumer via call center representative and described the occurrence of pain in a patient who received Herpes zoster (Shingrix) for prophylaxis.   In APR-2023, the patient received the 2nd dose of Shingrix. In APR-2023, an unknown time after receiving Shingrix, the patient experienced pain (Verbatim: Can I take a pain reliever for the side effects). The outcome of the pain was not resolved.   It was unknown if the reporter considered the pain to be related to Shingrix.     It was unknown if the company considered the pain to be related to Shingrix.   Additional Information: GSK receipt date: 18-Apr-2023 The patient just received my second shingles shot.  The patient wanted to know could we take a pain reliever for the side effect. The patient wanted to know is if it was safe to take a pain reliever after getting my 2nd shingles shot.
Systemic: Chest Tightness / Heaviness / Pain-Medium, Systemic: Confusion-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fainting / Unresponsive-Severe, Additional Details: Patient came in with mother. Received her vaccine first, got up and allowed mother to sit and receive her vaccine. Sooner after mother received vaccine pt (standing upright) began to fall over and lose contiousness. Mother and I were able to lower her to the ground where she regained contiousness a few seconds later. She appear very dazed and confused and could not stand up. We called 911 and the fire departmentand they arrived within minutes to check her. She was transported to ER.
I had the normal symptoms like they said to expect, I had body aches, chills, fever, I would get really hot and would sweat, and then I would got freezing cold. Then the next day my fever kept rising and it was up to 103.4, and it would not go down with any medicine that I was taking. I was very fatigue during this time and felt like I could not move. I called my Dr. and she advised that I was very dehydrated and that I needed to take sips of water, or Gatorade, or other fluids to help keep myself hydrated. She also advised to take certain amounts of Tylenol for up to an hour and if it did not go down then I would have to go to the emergency room, It began to finally drop to 103.0 then slowly to 100.00, I was just very very tired and fatigue. My first dose was very hard as well I just did not need to go the the Dr. for that one.
Two weeks after my shot I developed shingles on the back of my head on the left side. I went to an Urgent Care and they diagnosed me with shingles and gave me Valtrex. It lasted for a little over two weeks. Starting June 4 I have had shooting nerve pain all through my left arm. I have been to the ER twice and had two MRIs which have come back clean. My arm is unusable. My next course of action is an EMG.
Developed pain at the injection site within 12 hours and was swollen and red in large area (about 10 cm, looked like large welt but was not itchy, hurt to touch.) Took 1 week to resolve.
This spontaneous report as received from a nurse refers to a curently 3 months old patient of unknown gender. No information on the patient's concurrent conditions, medical history and concomitant medications was reported. On 17-JUL-2017, the patient was vaccinated with an improperly stored ROTATEQ orally, lot # N013885 (dose was not provided). Data logger was not involved. No adverse event was reported. The vaccine was stored in between 9 degrees Celsius (C) to 25 C for 3 hour and 45 minutes. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-1712USA004451: US-009507513-1712USA012874: US-009507513-1712USA012875: US-009507513-1712USA012876: US-009507513-1712USA012877: US-009507513-1712USA012878:
Chilling, fever, headache, dizziness, weakness. Finally went to doctor on 10/04/2013.
pt recv vax 21MAR95; 23MAR95 pt restless, started having sz; sz became constant 23MAR95 during day; sz described as jerking of head, arms, legs; pt saw MD 24MAR95; no meds or tests prescribed;no further pertussis d/t abn movement per MD
mom noted redness @ inj site LUE progressively got worse over a few days, now is red, hot & swollen;MD to treat w/augmentin dx as local subcutaneous reaction cellulitis;
shingles, including any and all of its sequelae; The information was received from a lawyer rand refers to a elderly male patient of unknown age. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On 04-FEB-2014, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) in a clinic for prophylaxis (dose, route of adminstration, lot # and expiration date were not reported). The patient was 64-years-old when he received zoster vaccine live (ZOSTAVAX) (reported as 65-years-old). As a result of his receipt of zoster vaccine live (ZOSTAVAX) in 2014, patient was caused to suffer shingles, including any and all of its sequelae. As a result of his receipt of zoster vaccine live (ZOSTAVAX), patient was caused to suffer severe personal injuries, pain, suffering, and emotional distress, as well as to incur substantial economic damages. As a result of the foregoing acts and omissions, the patient was caused to suffer serious and dangerous side effects including shingles as well as other severe and personal injuries which are permanent and lasting in nature, physical pain and mental anguish, including diminished enjoyment of life, as well as the need for lifelong medical treatment, monitoring and/or medications. As a result of the foregoing acts and omissions, the patient requires and/or will require more health care and services and did incur medical, health, he will int the future be required to obtain further medical and/or hospital care, attention and services. Patient also has suffered diminished capacity for the enjoyment of life, a diminished quality of life, increased risk of premature death, aggravation of preexisting conditions, activation of latent conditions, and other loses and damages. The reporter considered shingles to be related to zoster vaccine live (ZOSTAVAX).
No Adverse Event; Moderna COVID19 vaccine bivalent dose to a patient that had already received a Pfizer bivalent vaccine Patient received in the past; interchange of vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of COVID-19 IMMUNISATION (Moderna COVID19 vaccine bivalent dose to a patient that had already received a Pfizer bivalent vaccine Patient received in the past), INTERCHANGE OF VACCINE PRODUCTS (interchange of vaccine) and NO ADVERSE EVENT (No Adverse Event) in a 59-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 023h22a) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: PFIZER BIONTECH COVID-19 VACCINE ( 0.3ml ) on 14-Sep-2022. Past adverse reactions to the above products included No adverse event with PFIZER BIONTECH COVID-19 VACCINE.    On 15-Dec-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .5 milliliter. On an unknown date, the patient experienced COVID-19 IMMUNISATION (Moderna COVID19 vaccine bivalent dose to a patient that had already received a Pfizer bivalent vaccine Patient received in the past), INTERCHANGE OF VACCINE PRODUCTS (interchange of vaccine) and NO ADVERSE EVENT (No Adverse Event). At the time of the report, COVID-19 IMMUNISATION (Moderna COVID19 vaccine bivalent dose to a patient that had already received a Pfizer bivalent vaccine Patient received in the past), INTERCHANGE OF VACCINE PRODUCTS (interchange of vaccine) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessments were provided for COVID-19 IMMUNISATION (Moderna COVID19 vaccine bivalent dose to a patient that had already received a Pfizer bivalent vaccine Patient received in the past) and INTERCHANGE OF VACCINE PRODUCTS (interchange of vaccine).    No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD-2022-688242 (Patient Link).
pt recvd vax;exp paralysis from waist down;GBS; polymyositis; adm to hosp 7jan95; transferred to hlth ctr 10jan95;
Narrative:  COVID infections following completion of COVID vaccine series 03/18/21 COVID vaccine dose #1 07/11/21 Pt reports headache, rhinorrhea, coughing x2 days, and is COVID positive; given rx for benzonatate 07/13/21 Admitted to hospital with pneumonia in left lower lung, received remdesivir, dexamethasone, albuterol, azithromycin 07/17/21 Discharged home with oxygen 2 L 07/21/21 Pt presents to ED reporting SOB with cough x1 week following malfunctioning home oxygen that was not replaced by supplier; declined admission, leaving AMA, discharged with home oxygen; CTA thorax reveals no PE, positive for patchy bilateral opacities; COVID positive 07/23/21 Pt reports productive cough, SOB on exertion 07/26/21 Pt reports fatigue but is improving; given rx for ascorbic acid, DM/guaifenesin 07/29/21 Pt reports SOB on exertion and on 3L NC
pertussis, culture post hx of cough, wheezing, no paroxysmal cough; recvd vax 10JUL92;
Patient had a COVID Moderna vaccine  3/21/2021 at 1603. Patient felt nausea, headache, and tingling to left arm and feet (was anxious when reporting) at 1610. Patient was given water, laid  down in exam room with cool wet towels to head at 1620. Patient monitored until 1640 at which she felt better with resolution of tingling but mild headache and nausea continued.
Patient presented with fever, cough, malaise, fatigue, nausea and loss of appetite. Patient also reports loss of taste and vomiting x 1. Patient was treated with remdisivir and dexamethasone, and other supportive care.   Patient symptoms improve and patient was discharged on 07/23/2021
going down the arm from shoulder to elbow; warm to touch and swollen; warm to touch and swollen; arm was red; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 11-Mar-2021 and was forwarded to Moderna on 11-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (going down the arm from shoulder to elbow), FEELING HOT (warm to touch and swollen), SWELLING (warm to touch and swollen) and VACCINATION SITE ERYTHEMA (arm was red) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025AZIA) for COVID-19 vaccination.     The patient's past medical history included Diabetes (diabetes). Concurrent medical conditions included Food allergy (bananas), Allergy to antibiotic (Clindamycin), Egg allergy, Fruit allergy (watermelon) and Food allergy (Cantaloupe). Concomitant products included ZOLPIDEM TARTRATE (AMBIEN), DESVENLAFAXINE SUCCINATE (PRISTIQ), GABAPENTIN, LAMOTRIGINE, FENOFIBRATE, ATORVASTATIN and DEXLANSOPRAZOLE (DEXILANT) for an unknown indication.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced FEELING HOT (warm to touch and swollen), SWELLING (warm to touch and swollen) and VACCINATION SITE ERYTHEMA (arm was red). On 11-Mar-2021, the patient experienced PAIN IN EXTREMITY (going down the arm from shoulder to elbow). At the time of the report, PAIN IN EXTREMITY (going down the arm from shoulder to elbow), FEELING HOT (warm to touch and swollen) and SWELLING (warm to touch and swollen) had not resolved and VACCINATION SITE ERYTHEMA (arm was red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications were provided. Other concomitant medicines include Amphipoda   Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: Follow-Up Information Received on 16-JUN-2021 contains Non Significant Information
tongue numbness; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA ORAL (tongue numbness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA ORAL (tongue numbness). At the time of the report, HYPOAESTHESIA ORAL (tongue numbness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant Medication was provided. No treatment  was provided.
sigmoid colectomy on 8/2/21 with Doctor. Her hospitalization was complicated by an anastomotic leak requiring re-operation. ED visit to hospital admission. This visit was within 6 weeks of receiving the COVID vaccine.
Vaccine was given outside of recommended age group (patient was 17 years old at time of vaccination). Patient had symptoms in line with clinical trials (body aches, fatigue, flu) for 1.5 days after which they were feeling
The first event, 18th, I had a very long menstrual period. It lasted over four days (and that has never happened to me before). 2/18/2021 - 3/6/2021 or 3/7/2021. My doctor had to put me on an addition birth control short-term to stop that period. I started taking that medication on March 4th - March 8th. The last two months ( I have been off birth control - I am having significantly more bleeding then before. But I am on blood thinner.). June 13th - I woke up with a pain in my lower calf muscle - it felt like it was about to cramp constantly. I elevated and iced and felt a little better. But went to work 14th and it progressively got worse. Went to Urgent Care, thought it could be a blood clot. I started Eliquis that day - 10 mg twice a day. Imaging on the 15th - and saw blood clot on Ultrasound-  diagnosed with DVT.  I saw Dr on the 17th. He checked in with me on the blood thinner - for a week I took 10 mg twice a week and a week later he tapered it to 5 mg twice a day and he did bloodwork. My follow up appt is tomorrow. Six months from the event - go back to bloodwork and he'll take me off the blood thinner and do tests to see if there is an underlying cause. If not, they'll take me off the blood thinner and just monitor it. I still get significant swelling and pain on a regular basis anytime I'm up and around on my leg too much. It swells up. I am having intermittent pain from time to time.  They encouraged me to get off my birth control since there is risk from blood clots from that - so I did get off of that. My anxiety has been very significant since this event. I do have a history of anxiety in the past but it has very much increased. I use to be able to control my anxiety and it has now interfered with my personal and professional life.
No adverse reaction patient was given Hep B 20mcg/1ml instead of Hep B 10mg/ml.
1st Dose: Within 12 hours, fever, body aches, chills. Gone by next day. 2nd Dose: Within 12 hours, fever, body aches, chills, infrequent heart pain, nausea, vomiting, dull intestinal pain. Gone after day and a half. After two days, inflammation of muscle tissue underneath shot; skin was red, hot to touch, and raised/a lump. "Covid arm" lasted about a week; symptoms went away.